At CBI IRT 2025 in Boston, a panel moderated by Perceptive brought together experts from Regeneron, Takeda, and Astellas, to explore how protocol agility is reshaping expectations for IRT/RTSM systems. While the discussion offered practical insights, it also pointed to a broader industry imperative: the need to re-imagine IRT/RTSM as a strategic enabler of adaptive trial design.
Click the link below to read the insight piece in full.
